The UK knee orthosis market revenue saw consistent growth from 2020, with acceleration in the post-pandemic era due to delayed treatments and rising elective surgeries. In 2025, revenue is projected to reach 420 million USD, with a CAGR of 5.3% through 2035, driven by demographic shifts and technological advancements. Digital health integration and homecare trends are set to sustain long-term growth.

Read More - https://bussinessinsights.com/research-report/uk-knee-orthosis-(ko)

Ligament injuries represent the highest market share in the application segment, reflecting strong demand from sports medicine and trauma cases. Osteoarthritis is a critical growth driver, boosted by an expanding elderly demographic. Preventive care and post-operative rehabilitation also hold significant shares as awareness and clinical adoption of orthoses rise.

Request Free Sample- https://bussinessinsights.com/request/medical-devices/uk-knee-orthosis-(ko)

Frequently Asked Questions

Who are the key players in UK Knee Orthosis (KO) industry?
The top five key players in the UK Knee Orthosis industry are Össur, DJO Global (Enovis), Bauerfeind AG, Ottobock, and Thuasne Group. These companies are renowned for their innovation, broad product portfolios, and strong distribution channels, positioning them as leaders in the UK orthopedic support market.

What is the UK Knee Orthosis (KO) growth?
The UK Knee Orthosis market has shown steady growth, with companies like Össur and Ottobock reporting increased demand in 2023 due to rising sports injuries and an aging population. Recent advancements in lightweight, custom-fit orthoses are also contributing to market expansion and higher patient adoption rates.

Which segment accounted for the largest UK Knee Orthosis (KO) share?
The rehabilitation and pain management segment accounted for the largest share in the UK KO market, driven by the growing incidence of osteoarthritis and post-surgical recovery needs. Hospitals and orthopedic clinics dominate distribution, reflecting the high volume of knee injuries treated within institutional healthcare settings.

Thanks & Regards,
Manisha C
sales@bussinessinsights.com